- 全部删除
您的购物车当前为空
NLRP3-IN-44 (compound P33) 作为一款高效的口服NLRP3抑制剂,其生物利用度约为 62%,KD 值达到 17.5 nM。该化合物在研究由NLRP3炎症小体调控的疾病中扮演着关键角色。

NLRP3-IN-44 (compound P33) 作为一款高效的口服NLRP3抑制剂,其生物利用度约为 62%,KD 值达到 17.5 nM。该化合物在研究由NLRP3炎症小体调控的疾病中扮演着关键角色。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
NLRP3-IN-44 相关产品
| 产品描述 | NLRP3-IN-44 (compound P33), an orally active (approximately 62%) and potent inhibitor of NLRP3, exhibits a dissociation constant (K D) of 17.5 nM. This compound is crucial in the research of diseases mediated by the NLRP3 inflammasome. |
| 分子量 | 434.53 |
| 分子式 | C25H30N4O3 |
| CAS No. | 3040298-34-5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容